Interview

Hemant Taneja on AI-era growth rates, healthcare transformation, and why venture is becoming beta

Oct 17, 2025 with Hemant Taneja

Key Points

  • AI has reset venture growth benchmarks: General Catalyst now routinely sees companies scale from $1M to $15M–$20M ARR in timeframes that would have been exceptional in prior cycles.
  • Most AI wrapper companies built on foundation models lack durability; only those doing forward-deployed engineering inside enterprises or redefining human interaction with software compound customer relationships.
  • General Catalyst acquired a health system in Akron, Ohio to prove longevity-oriented care can become reimbursable, targeting a structural misalignment where insurers resist preventive investment due to patient churn risk.
Hemant Taneja on AI-era growth rates, healthcare transformation, and why venture is becoming beta

Summary

Hemant Taneja, CEO of General Catalyst, argues that AI-era growth rates have fundamentally reset the benchmark for venture-backed companies. Where Samsara represented a rare outlier in the previous cycle, GC is now routinely seeing companies scale from $1M to $15M–$20M ARR in timeframes that would have been exceptional before. Taneja frames this not as hype but as an empirical observation, one that prompted him to formally recalibrate the firm's internal definition of best-in-class growth.

Durability Is the Real Question

Taneja draws a sharp distinction between two categories of fast-growing AI companies. Firms doing forward-deployed engineering inside large enterprises, building trust and expanding scope over time, are accumulating durable relationships. Those building thin wrappers on foundation models are largely not. He points to the GPT-3 wave as a precedent: many companies appeared quickly and vanished just as fast. The exception is a subset of wrapper-layer products that are redefining human interaction with software and represent genuine cultural movements rather than feature releases.

His framework for evaluating applied AI entrants centers on one question: is the company learning how to expand its relationship with each customer, or is it selling a point solution? The former compounds. The latter is structurally fragile.

Healthcare as a 20-Year Systems Bet

GC has been building in healthcare for roughly a decade, with a portfolio that includes Livongo, Hippocratic AI, Commure (described as likely the largest software company serving health systems), Transcarent, AIDoc, SOAR, Cityblock, and Homeworld Healthcare. Taneja identifies two active investment fronts: seed-stage companies applying AI to life sciences and health delivery, and a cohort of approximately 25–30 growth-stage companies that emerged from the pandemic era and are now scaling.

General Catalyst recently acquired a health system in Akron, Ohio, described as the city's largest employer, with both a hospital network and an insurance company. The rationale is to demonstrate that longevity-oriented care can become reimbursable, something the current insurance market structurally resists. Insurers decline to fund preventive or longevity investment because patient churn means they are unlikely to capture the long-term ROI. Taneja calls this the core misalignment holding back health system reform.

On rural health, the firm is watching a $50 billion federal allocation for rural health system rebuilding. Taneja is explicit that deploying that capital into traditional hospital infrastructure would be a mistake. GC has built Homeworld Healthcare to address this and is building future-state hospital models in India first, with the intent to import learnings to the US over a 20-year horizon.

Venture Is Becoming Beta Without Differentiation

Taneja raises a structural concern about the asset class: as capital access democratizes and late-stage rounds become very large, venture returns risk compressing toward beta. His argument is that firms unwilling to take on genuine transformation risk, working on large, complex, multi-stakeholder problems, will find it difficult to justify the illiquidity premium LPs are paying. GC's response is to position itself explicitly as a systems-transformation platform rather than a serendipitous capital allocator.

GC manages approximately $40 billion in AUM. The firm allocates roughly two-thirds to the US, 25% to Europe, and 10% to India. It has built or backed defense primes in each geography: Anduril in the US, Helsing in Europe, and Rafael in India. Taneja has been an investor in Stripe since 2010 and has invested in the company 14 times since, citing it as a model for the 30–40 year founder relationships he wants GC to build.

On Media and Talent

Taneja is skeptical of attention-maximizing media strategies in venture. His view is that the pursuit of social media scale pushes investors toward increasingly fringe positions to remain visible, which corrodes judgment over time. He distinguishes purposeful media, designed to shift cultural and policy narratives toward a desired future, from personal brand building, which he sees as a failure mode.

On hiring, he prioritizes genuine sense of purpose over credential or career intent. His observation is that the investors who have built lasting track records did not choose venture strategically. They arrived through idiosyncratic paths driven by something they wanted to build or fix. Taneja himself joined GC in 2002 at age 26 for what he expected to be four months, after what he describes as a failed company.